Target intelligence / Profile preview

Enzymatic pathways

Molecular classification
Other
01

Overview

Enzymatic pathways encompass interconnected series of enzyme-catalyzed reactions that underpin nearly all cellular processes, from breaking down nutrients like proteins, fats, and carbohydrates to synthesizing complex molecules and generating energy via pathways such as glycolysis and the citric acid cycle. These pathways are tightly regulated by mechanisms like feedback inhibition, allosteric modulation, and phosphorylation to match cellular needs, ensuring efficient metabolism under varying conditions. Dysregulation of enzymatic pathways contributes to diseases including cancer (e.g., altered amino acid metabolism), lysosomal storage disorders (e.g., enzyme deficiencies leading to substrate accumulation), metabolic conditions like phenylketonuria, and fibrosis from excess extracellular matrix buildup. Therapeutically, specific enzymes within these pathways are targeted via replacement therapies, such as glucocerebrosidase for Gaucher's disease or collagenase for fibrotic plaques, and inhibitors like kinase blockers for pathway modulation in oncology. Drugs interacting with pathway enzymes often face challenges like poor stability and immunogenicity, spurring innovations in targeted delivery and proximity-based activation. Overall, enzymatic pathways represent a broad therapeutic landscape where modulating individual enzymes can restore balance in disease states.

Other names
metabolic pathwaysbiochemical pathwaysmetabolic routes
02

Mechanism of action

Enzyme replacement therapy, Prodrug activation, Substrate degradation, Inhibition of key pathway enzymes

03

Biological functions

MetabolismSignal transductionCell regulationEnergy productionBiosynthesis
04

Disease associations

CancerLysosomal storage diseasesMetabolic deficienciesFibrosisCardiovascular diseaseInflammation
05

Safety considerations

Immunogenicity of exogenous enzymesOff-target tissue damageShort half-life requiring frequent dosingDelivery challenges across barriers like BBB
06

Interacting drugs

Glucocerebrosidase (Cerezyme)

5 more in the full profile.

Beyond the preview

Go deeper on Enzymatic pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enzymatic pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call